Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CBRL
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 7.13 0.63 0.58
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 61.23 31.11 19.30
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -7.69 19.21 20.81
Cash -5.97 0.53 0.57
Capex -9.84 -1.32 -1.20
Free Cash Flow -83.90 0.37 2.29
Revenue -12.66 36.80 42.14
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -13.58 0.08 0.09
Operating Margin -68.89 0.01 0.03
ROA -64.88 < 0.005 0.01
ROE -62.45 -0.02 0.06
ROIC -89.93 < 0.005 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CBRL is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CBRL is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CBRL is permitted for members.